DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 02 · Volume 48 · March 2015 DOI: 10.1055/s-005-28734

AGNP News

I
Steiger, A.: AGNP-Preis für Forschung in der Psychopharmakologie

Review

41
Buoli, M.; Altamura, A. C.: May Non-antipsychotic Drugs Improve Cognition of Schizophrenia Patients?

Original Paper

51
Toledo-Romero, F.; Molina, J. D.; López-Rodríguez, E.; Amorin-Díaz, M.; Muñoz Algar, M. J.; Aparicio-Castro, E.: Augmentation with Amisulpride for Schizophrenic Patients Non-Responsive to Risperidone Monotherapy
58
Tsai, H. C.; Lin, S.-H.; Chen, P. S.; Chang, H. H.; Lee, I. H.; Yeh, T. L.; Chen, K. C.; Chiu, N. T.; Yao, W. J.; Liao, M.-H.; Yang, Y. K.: Quantifying Midbrain Serotonin Transporter in Depression: A Preliminary Study of Diagnosis and Naturalistic Treatment Outcome
65
Brunnauer, A.; Buschert, V.; Fric, M.; Distler, G.; Sander, K.; Segmiller, F.; Zwanzger, P.; Laux, G.: Driving Performance and Psychomotor Function in Depressed Patients Treated with Agomelatine or Venlafaxine
72
Wolf, L.; Bauer, A.; Melchner, D.; Hallof-Buestrich, H.; Stoertebecker, P.; Haen, E.; Kreutz, M.; Sarubin, N.; Milenkovic, V. M.; Wetzel, C. H.; Rupprecht, R.; Nothdurfter, C.: Enhancing Neurosteroid Synthesis – Relationship to the Pharmacology of Translocator Protein (18 kDa) (TSPO) Ligands and Benzodiazepines

Letter

78
Permoda-Osip, A.; Kisielewski, J.; Bartkowska-Sniatkowska, A.; Rybakowski, J. K.: Single Ketamine Infusion and Neurocognitive Performance in Bipolar Depression
80
Rickels, K.: Re: Over-the-Counter Drugs for the Treatment of Mood and Anxiety Disorders – The Views of German Pharmacists. By J. Hamann, K. Linde, H. D. Schweiger, O. Kusmakow, H. Foerstl, Pharmacopsychiatry 2014; 47: 84–88

Erratum

81
Proft, F.; Kopf, J.; Olmes, D.; Hempel, S.; Schmidt, B.; Riederer, P.; Deckert, J.; Pfuhlmann, B.; Reif, A.; Unterecker, S.: SLC6A2 and SLC6A4 Variants interact with Venlafaxine Serum Concentrations to Influence Therapy Outcome